Biological testing unification for hemodialysis membranes evaluation: A step towards standardization

Area of Science:

• Biomaterials Science
• Nephrology
• Medical Device Evaluation

Background:

• Current hemodialysis membranes cause adverse effects, necessitating improved materials and evaluation methods.
• Existing evaluation protocols lack standardization, hindering accurate assessment of new hemodialysis membranes.
• Urgent need exists for minimum guidelines to evaluate the performance and biocompatibility of novel hemodialysis membranes.

Purpose of the Study:

• To propose standardized biological tests and variables for evaluating new hemodialysis membranes.
• To establish minimum testing guidelines that closely replicate in vivo hemodialysis conditions.
• To ensure the biocompatibility, effectiveness, and efficiency of hemodialysis membranes.

Main Methods:

• Categorization of tests into protein adsorption, transmission, platelet adhesion/activation, coagulation, hemolysis, complement activation, and cytotoxicity.
• Recommendation of dynamic crossflow systems (>250 mL/min) with specific mimicking solutions for protein adsorption.
• Advocacy for dynamic conditions with human blood/plasma for protein transmission, complement activation, and hemolysis tests over 3.5 hours.

Main Results:

• Specific protocols outlined for each biological test category, including recommended conditions and assays.
• Emphasis on dynamic testing mimicking physiological flow and conditions for accurate membrane assessment.
• Integration of multiple assays for cytotoxicity testing and use of diverse cell types for validation.

Conclusions:

• Implementing these standardized minimum biological tests will improve the accuracy of hemodialysis membrane evaluations.
• Standardized testing ensures better reflection of real-world performance, enhancing patient safety.
• This framework supports the development and clinical adoption of safer and more effective hemodialysis membranes.